$1.92
Market Cap
$3.02M
Shares Outstanding
1.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 4, 2018
Round Lot
100
Locale
US
Day Open
$1.95
Day High
$2.65
Day Low
$1.74
Volume
7.22M
VWAP
$2.12
Prev Close
$1.66
Transactions
--
Acc. Volume
--
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
XORTX Therapeutics Inc. Common Stock (XRTX) closed the 2026-09-18 session at $1.92, up 15.66% versus the previous close (+0.26). The stock opened at $1.95 and traded between $1.74 and $2.65 during that session. Session trading volume was 7.2M shares. The volume-weighted average price (VWAP) is $2.12.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
XORTX Therapeutics Inc. Common Stock has a market capitalization of $3.0 million. XRTX is listed on the XNAS exchange. The company employs approximately 3 people. The recorded listing date is 2018-05-04.
On this page you can find market XRTX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.